“gene-therapy” Archives

in
Entry Author Date Location
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Passage Bio’s IPO Raises $216M to Fund Gene Therapy Studies 02/28/20 National
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
New Meds Set to Reshape US CNS and Oncology Markets 02/18/20 National
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic 02/03/20 New York
Discovery Labs Converts ex-GSK King of Prussia Site into R&D “Colony” 02/03/20 New York
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus 01/29/20 Boston
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D 01/15/20 New York
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track 01/09/20 Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options 12/19/19 Boston
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI 12/03/19 San Diego
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer 12/03/19 National
La Jolla Pharma’s Share Price Halves On Trial End, CEO Departure 11/26/19 San Diego
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial 11/12/19 Boston
Page 2 of 16 « previous page · next page »